Creekmur Asset Management LLC Intellia Therapeutics, Inc. Transaction History
Creekmur Asset Management LLC
- $566 Billion
- Q2 2025
A detailed history of Creekmur Asset Management LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Creekmur Asset Management LLC holds 58,600 shares of NTLA stock, worth $632,294. This represents 0.1% of its overall portfolio holdings.
Number of Shares
58,600
Previous 40,946
43.12%
Holding current value
$632,294
Previous $291 Million
88.81%
% of portfolio
0.1%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding NTLA
# of Institutions
345Shares Held
98.8MCall Options Held
784KPut Options Held
713K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl13MShares$140 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$116 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$104 Million0.0% of portfolio
-
State Street Corp Boston, MA4.51MShares$48.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.8MShares$41 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $820M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...